RAF1 in particular has been recognized as a major effector whose gain-of-function mutations cause Noonan and LEOPARD syndromes, emphasizing the importance of the ERK pathway activation in developmental disorders (151, 152). Here, RAF1 is linked to Noonan syndrome with multiple lentigines.